Literature DB >> 19877058

Impaired myofibrillar function in the soleus muscle of mice with collagen-induced arthritis.

Takashi Yamada1, Nicolas Place, Natalia Kosterina, Therese Ostberg, Shi-Jin Zhang, Cecilia Grundtman, Helena Erlandsson-Harris, Ingrid E Lundberg, Birgitta Glenmark, Joseph D Bruton, Håkan Westerblad.   

Abstract

OBJECTIVE: Progressive muscle weakness is a common feature in patients with rheumatoid arthritis (RA). However, little is known about whether the intrinsic contractile properties of muscle fibers are affected in RA. This study was undertaken to investigate muscle contractility and the myoplasmic free Ca2+ concentration ([Ca2+](i)) in the soleus, a major postural muscle, in mice with collagen-induced arthritis (CIA).
METHODS: Muscle contractility and [Ca2+](i) were assessed in whole muscle and intact single-fiber preparations, respectively. The underlying mechanisms of contractile dysfunction were assessed by investigating redox modifications using Western blotting and antibodies against nitric oxide synthase (NOS), superoxide dismutase (SOD), 3-nitrotyrosine (3-NT), carbonyl, malondialdehyde (MDA), and S-nitrosocysteine (SNO-Cys).
RESULTS: The tetanic force per cross-sectional area was markedly decreased in the soleus muscle of mice with CIA, and the change was not due to a decrease in the amplitude of [Ca2+](i) transients. The reduction in force production was accompanied by slowing of the twitch contraction and relaxation and a decrease in the maximum shortening velocity. Immunoblot analyses showed a marked increase in neuronal NOS expression but not in inducible or endothelial NOS expression, which, together with the observed decrease in SOD2 expression, favors peroxynitrite formation. These changes were accompanied by increased 3-NT, carbonyl, and MDA adducts content in myofibrillar proteins from the muscles of mice with CIA. Moreover, there was a significant increase in SNO-Cys content in myosin heavy-chain and troponin I myofibrillar proteins from the soleus muscle of mice with CIA.
CONCLUSION: These findings show impaired contractile function in the soleus muscle of mice with CIA and suggest that this abnormality is due to peroxynitrite-induced modifications in myofibrillar proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19877058     DOI: 10.1002/art.24907

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  23 in total

1.  S-Nitrosylation of Sarcomeric Proteins Depresses Myofilament Ca2+)Sensitivity in Intact Cardiomyocytes.

Authors:  Cícero Figueiredo-Freitas; Raul A Dulce; Matthew W Foster; Jingsheng Liang; Aline M S Yamashita; Frederico L Lima-Rosa; J Will Thompson; M Arthur Moseley; Joshua M Hare; Leonardo Nogueira; Martha M Sorenson; José Renato Pinto
Journal:  Antioxid Redox Signal       Date:  2015-11-01       Impact factor: 8.401

Review 2.  Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease.

Authors:  Michael B Reid; Jennifer S Moylan
Journal:  J Physiol       Date:  2011-02-14       Impact factor: 5.182

Review 3.  Skeletal muscle Ca(2+) mishandling: Another effect of bone-to-muscle signaling.

Authors:  Jenna N Regan; David L Waning; Theresa A Guise
Journal:  Semin Cell Dev Biol       Date:  2015-11-24       Impact factor: 7.727

4.  ROS-mediated decline in maximum Ca2+-activated force in rat skeletal muscle fibers following in vitro and in vivo stimulation.

Authors:  Travis L Dutka; Esther Verburg; Noni Larkins; Kristin H Hortemo; Per K Lunde; Ole M Sejersted; Graham D Lamb
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

5.  Leaky ryanodine receptors in β-sarcoglycan deficient mice: a potential common defect in muscular dystrophy.

Authors:  Daniel C Andersson; Albano C Meli; Steven Reiken; Matthew J Betzenhauser; Alisa Umanskaya; Takayuki Shiomi; Jeanine D'Armiento; Andrew R Marks
Journal:  Skelet Muscle       Date:  2012-05-28       Impact factor: 4.912

6.  Nitrosative modifications of the Ca2+ release complex and actin underlie arthritis-induced muscle weakness.

Authors:  Takashi Yamada; Olga Fedotovskaya; Arthur J Cheng; Anabelle S Cornachione; Fabio C Minozzo; Cecilia Aulin; Cecilia Fridén; Carl Turesson; Daniel C Andersson; Birgitta Glenmark; Ingrid E Lundberg; Dilson E Rassier; Håkan Westerblad; Johanna T Lanner
Journal:  Ann Rheum Dis       Date:  2014-05-22       Impact factor: 19.103

7.  Muscle dysfunction associated with adjuvant-induced arthritis is prevented by antioxidant treatment.

Authors:  Takashi Yamada; Masami Abe; Jaesik Lee; Daisuke Tatebayashi; Koichi Himori; Keita Kanzaki; Masanobu Wada; Joseph D Bruton; Håkan Westerblad; Johanna T Lanner
Journal:  Skelet Muscle       Date:  2015-07-09       Impact factor: 4.912

8.  Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension.

Authors:  Koichi Himori; Masami Abe; Daisuke Tatebayashi; Jaesik Lee; Håkan Westerblad; Johanna T Lanner; Takashi Yamada
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

9.  Excess TGF-β mediates muscle weakness associated with bone metastases in mice.

Authors:  David L Waning; Khalid S Mohammad; Steven Reiken; Wenjun Xie; Daniel C Andersson; Sutha John; Antonella Chiechi; Laura E Wright; Alisa Umanskaya; Maria Niewolna; Trupti Trivedi; Sahba Charkhzarrin; Pooja Khatiwada; Anetta Wronska; Ashley Haynes; Maria Serena Benassi; Frank A Witzmann; Gehua Zhen; Xiao Wang; Xu Cao; G David Roodman; Andrew R Marks; Theresa A Guise
Journal:  Nat Med       Date:  2015-10-12       Impact factor: 53.440

10.  Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs.

Authors:  Rafael Barreto; David L Waning; Hongyu Gao; Yunlong Liu; Teresa A Zimmers; Andrea Bonetto
Journal:  Oncotarget       Date:  2016-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.